½ÃÀ庸°í¼­
»óǰÄÚµå
1748504

¼¼°èÀÇ Àΰ£È­ ¸¶¿ì½º ¸ðµ¨ ½ÃÀå(2025-2029³â)

Global Humanized Mouse Model Market 2025-2029

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: TechNavio | ÆäÀÌÁö Á¤º¸: ¿µ¹® 214 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Àΰ£È­ ¸¶¿ì½º ¸ðµ¨ ½ÃÀåÀº 2024-2029³â 6,160¸¸ ´Þ·¯ Áõ°¡Çϰí, ¿¹Ãø ±â°£ µ¿¾È CAGR 6.7%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Àΰ£È­ ¸¶¿ì½º ¸ðµ¨ ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø, µ¿Çâ, ¼ºÀå ÃËÁø¿äÀÎ, °úÁ¦, ¾à 25°³ º¥´õ¸¦ Æ÷ÇÔÇÑ º¥´õ ºÐ¼® µîÀÇ Á¤º¸¸¦ ÀüÇØµå¸³´Ï´Ù.

ÇöÀç ½ÃÀå ½Ã³ª¸®¿À, Ãֽе¿Çâ ¹× ÃËÁø¿äÀÎ, ½ÃÀå ȯ°æ Àü¹Ý¿¡ ´ëÇÑ ÃֽŠºÐ¼®À» Á¦°øÇÕ´Ï´Ù. ÀÌ ½ÃÀåÀº ¸ÂÃãÇü ÀÇ·áÀÇ Ã¤Åà Ȯ´ë, Àΰ£È­ ¸¶¿ì½º ¸ðµ¨ÀÇ Çõ½ÅÀûÀÎ Àû¿ë, À¯Àü°øÇÐ ±â¼úÀÇ ¹ßÀü¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù.

½ÃÀå ¹üÀ§
±âÁØ ¿¬µµ 2025³â
Á¾·á ¿¬µµ 2029³â
¿¹Ãø ±â°£ 2025-2029³â
¼ºÀå ¸ð¸àÅÒ °¡¼Ó
Àü³âºñ 6.5%
CAGR 6.7%
Áõ°¡¾× 6,160¸¸ ´Þ·¯

ÀÌ Á¶»ç´Â ¾÷°è ÁÖ¿ä Âü°¡ÀÚÀÇ ÀǰßÀ» Æ÷ÇÔÇÏ¿© 1Â÷ ¹× 2Â÷ Á¤º¸¸¦ °´°üÀûÀ¸·Î °áÇÕÇÏ¿© ¼öÇàµÇ¾ú½À´Ï´Ù. ÀÌ º¸°í¼­¿¡´Â ÁÖ¿ä ±â¾÷ ºÐ¼®, Á¾ÇÕÀûÀÎ ½ÃÀå ±Ô¸ð µ¥ÀÌÅÍ, Áö¿ª ºÐ¼®¿¡ µû¸¥ ºÎ¹®, °ø±Þ¾÷ü ÇöȲÀÌ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. º¸°í¼­¿¡´Â °ú°Å µ¥ÀÌÅÍ¿Í ¿¹Ãø µ¥ÀÌÅͰ¡ ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÇâÈÄ ¸î ³â°£ Àΰ£È­ ¸¶¿ì½º ¸ðµ¨ ½ÃÀåÀÇ ¼ºÀåÀ» ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎ Áß Çϳª·Î ±â¾÷ÀÇ Àü·«Àû Á¦ÈÞ¸¦ ²Å¾Ò½À´Ï´Ù. ¶ÇÇÑ, mabsÀÇ »ý»ê·® Áõ°¡¿Í Àüü µ¿¹° À̹Ì¡ÀÇ ÃâÇöÀº ½ÃÀåÀÇ Å« ¼ö¿ä·Î À̾îÁú °ÍÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

  • ½ÃÀå °³¿ä

Á¦2Àå Technavio ºÐ¼®

  • °¡°Ý¡¤¼ö¸íÁֱ⡤°í°´ ±¸ÀÔ ¹Ù½ºÄÏ¡¤Ã¤¿ë·ü¡¤±¸ÀÔ ±âÁØ ºÐ¼®
  • ÀÎDzÀÇ Á߿伺°ú Â÷º°È­ ¿äÀÎ
  • È¥¶õ ¿äÀÎ
  • ¼ºÀå ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ

Á¦3Àå ½ÃÀå »óȲ

  • ½ÃÀå »ýŰè
  • ½ÃÀå Æ¯Â¡
  • ¹ë·ùüÀÎ ºÐ¼®

Á¦4Àå ½ÃÀå ±Ô¸ð

  • ½ÃÀå Á¤ÀÇ
  • ½ÃÀå ºÎ¹® ºÐ¼®
  • ½ÃÀå ±Ô¸ð 2024³â
  • ½ÃÀå Àü¸Á 2024-2029³â

Á¦5Àå ½ÃÀå ±Ô¸ð ½ÇÀû

  • Àΰ£È­ ¸¶¿ì½º ¸ðµ¨ ¼¼°è ½ÃÀå 2019-2023³â
  • Á¦Ç° À¯Çüº° ºÎ¹® ºÐ¼® 2019-2023³â
  • ÃÖÁ¾»ç¿ëÀÚº° ºÎ¹® ºÐ¼® 2019-2023³â
  • ¿ëµµº° ºÎ¹® ºÐ¼® 2019-2023³â
  • Áö¿ªº° ºÎ¹® ºÐ¼® 2019-2023³â
  • ±¹°¡º° ºÎ¹® ºÐ¼® 2019-2023³â

Á¦6Àå Á¤¼º ºÐ¼®

  • AIÀÇ ¿µÇâ : Àΰ£È­ ¸¶¿ì½º ¸ðµ¨ ¼¼°è ½ÃÀå

Á¦7Àå Five Forces ºÐ¼®

  • Five Forces ¿ä¾à
  • ±¸¸ÅÀÚÀÇ ±³¼··Â
  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
  • ´ëüǰÀÇ À§Çù
  • °æÀïÀÇ À§Çù
  • ½ÃÀå »óȲ

Á¦8Àå ½ÃÀå ¼¼ºÐÈ­ : Á¦Ç° À¯Çüº°

  • ½ÃÀå ºÎ¹®
  • ºñ±³ : Á¦Ç° À¯Çüº°
  • GHMM : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
  • ¼¿ ±â¹Ý Àΰ£È­ ¸¶¿ì½º ¸ðµ¨ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
  • ½ÃÀå ±âȸ : Á¦Ç° À¯Çüº°

Á¦9Àå ½ÃÀå ¼¼ºÐÈ­ : ÃÖÁ¾»ç¿ëÀÚº°

  • ½ÃÀå ºÎ¹®
  • ºñ±³ : ÃÖÁ¾»ç¿ëÀÚº°
  • Á¦¾à ¹× ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö ±â¾÷ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
  • CRO : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
  • Çмú¿¬±¸±â°ü : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
  • ½ÃÀå ±âȸ : ÃÖÁ¾»ç¿ëÀÚº°

Á¦10Àå ½ÃÀå ¼¼ºÐÈ­ : ¿ëµµº°

  • ½ÃÀå ºÎ¹®
  • ºñ±³ : ¿ëµµº°
  • Á¾¾çÇÐ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
  • ¸é¿ªÇаú °¨¿°Áõ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
  • ½Å°æ°úÇÐ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
  • µ¶¹°Çаú Á¶Ç÷ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
  • ½ÃÀå ±âȸ : ¿ëµµº°

Á¦11Àå °í°´ »óȲ

  • °í°´ »óȲ °³¿ä

Á¦12Àå Áö¿ªº° »óȲ

  • Áö¿ªº° ¼¼ºÐÈ­
  • Áö¿ªº° ºñ±³
  • ºÏ¹Ì : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
  • À¯·´ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
  • ¾Æ½Ã¾Æ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
  • ¼¼°è ±âŸ Áö¿ª : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
  • ¹Ì±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
  • Áß±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
  • µ¶ÀÏ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
  • ÇÁ¶û½º : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
  • ij³ª´Ù : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
  • ÀϺ» : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
  • ºê¶óÁú : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
  • ¿µ±¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
  • Àεµ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
  • Çѱ¹ : ½ÃÀå ±Ô¸ð¿Í ¿¹Ãø 2024-2029³â
  • ½ÃÀå ±âȸ : Áö¿ª »óȲº°

Á¦13Àå ÃËÁø¿äÀÎ, °úÁ¦, ±âȸ, ¾ïÁ¦¿äÀÎ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
  • ½ÃÀå °úÁ¦
  • ¼ºÀå ÃËÁø¿äÀΰú °úÁ¦ÀÇ ¿µÇâ
  • ½ÃÀå ±âȸ¡¤¾ïÁ¦¿äÀÎ

Á¦14Àå °æÀï ±¸µµ

  • °³¿ä
  • °æÀï ±¸µµ
  • È¥¶õ »óȲ
  • ¾÷°è ¸®½ºÅ©

Á¦15Àå °æÀï ºÐ¼®

  • ±â¾÷ °³¿ä
  • ±â¾÷ ¼øÀ§ Áö¼ö
  • ±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´×
  • Altogen labs
  • Aragen Life Sciences Pvt. Ltd.
  • Biocytogen Pharmaceuticals Co. Ltd.
  • BioSafety Research Center Inc.
  • Champions Oncology Inc.
  • Charles River Laboratories International Inc.
  • Creative Biolabs
  • Cyagen Biosciences
  • Gempharmatech Co. Ltd.
  • GenOway
  • HBM Holdings Ltd.
  • Hera Biolabs Inc.
  • ingenious targeting laboratory
  • JSR Corp.
  • Perkin Elmer Inc.

Á¦16Àå ºÎ·Ï

ksm 25.06.23

The humanized mouse model market is forecasted to grow by USD 61.6 mn during 2024-2029, accelerating at a CAGR of 6.7% during the forecast period. The report on the humanized mouse model market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing adoption of personalized medicine, innovative applications of humanized mouse models, and advancements in genetic engineering technologies.

Market Scope
Base Year2025
End Year2029
Series Year2025-2029
Growth MomentumAccelerate
YOY 20256.5%
CAGR6.7%
Incremental Value$61.6 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's humanized mouse model market is segmented as below:

By Product Type

    • GHMM
    • Cell-based humanized mouse model

By End-user

    • Pharmaceutical and biotechnology companies
    • CROs
    • Academic and research institutions

By Application

    • Oncology
    • Immunology and infectious diseases
    • Neuroscience
    • Toxicology and hematopoiesis

By Geographical Landscape

    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

This study identifies the strategic alliances of companies as one of the prime reasons driving the humanized mouse model market growth during the next few years. Also, increasing production of mabs and emergence of whole animal imaging will lead to sizable demand in the market.

The report on the humanized mouse model market covers the following areas:

    • Humanized Mouse Model Market sizing
    • Humanized Mouse Model Market forecast
    • Humanized Mouse Model Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading humanized mouse model market vendors that include Altogen labs, Aragen Life Sciences Pvt. Ltd., Biocytogen Pharmaceuticals Co. Ltd., BioSafety Research Center Inc., Champions Oncology Inc., Charles River Laboratories International Inc., Creative Biolabs, Cyagen Biosciences, Gempharmatech Co. Ltd., GenOway, HBM Holdings Ltd., Hera Biolabs Inc., ingenious targeting laboratory, Inotiv Inc., JANVIER LABS, JSR Corp., Oncodesign Precision Medicine, Ozgene Pty Ltd., Perkin Elmer Inc., and Pharmatest services. Also, the humanized mouse model market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
    • Executive Summary - Chart on Market Overview
    • Executive Summary - Data Table on Market Overview
    • Executive Summary - Chart on Global Market Characteristics
    • Executive Summary - Chart on Market By Geographical Landscape
    • Executive Summary - Chart on Market Segmentation by Product Type
    • Executive Summary - Chart on Market Segmentation by End-user
    • Executive Summary - Chart on Market Segmentation by Application
    • Executive Summary - Chart on Incremental Growth
    • Executive Summary - Data Table on Incremental Growth
    • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

  • 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • 2.2 Criticality of inputs and Factors of differentiation
    • Overview on criticality of inputs and factors of differentiation
  • 2.3 Factors of disruption
    • Overview on factors of disruption
  • 2.4 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

  • 3.1 Market ecosystem
    • Parent Market
    • Data Table on - Parent Market
  • 3.2 Market characteristics
    • Market characteristics analysis
  • 3.3 Value chain analysis
    • Value chain analysis

4 Market Sizing

  • 4.1 Market definition
    • Offerings of companies included in the market definition
  • 4.2 Market segment analysis
    • Market segments
  • 4.3 Market size 2024
  • 4.4 Market outlook: Forecast for 2024-2029
    • Chart on Global - Market size and forecast 2024-2029 ($ million)
    • Data Table on Global - Market size and forecast 2024-2029 ($ million)
    • Chart on Global Market: Year-over-year growth 2024-2029 (%)
    • Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

  • 5.1 Global Humanized Mouse Model Market 2019 - 2023
    • Historic Market Size - Data Table on Global Humanized Mouse Model Market 2019 - 2023 ($ million)
  • 5.2 Product Type segment analysis 2019 - 2023
    • Historic Market Size - Product Type Segment 2019 - 2023 ($ million)
  • 5.3 End-user segment analysis 2019 - 2023
    • Historic Market Size - End-user Segment 2019 - 2023 ($ million)
  • 5.4 Application segment analysis 2019 - 2023
    • Historic Market Size - Application Segment 2019 - 2023 ($ million)
  • 5.5 Geography segment analysis 2019 - 2023
    • Historic Market Size - Geography Segment 2019 - 2023 ($ million)
  • 5.6 Country segment analysis 2019 - 2023
    • Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

  • 6.1 Impact of AI on Global Humanized Mouse Model Market

7 Five Forces Analysis

  • 7.1 Five forces summary
    • Five forces analysis - Comparison between 2024 and 2029
  • 7.2 Bargaining power of buyers
    • Bargaining power of buyers - Impact of key factors 2024 and 2029
  • 7.3 Bargaining power of suppliers
    • Bargaining power of suppliers - Impact of key factors in 2024 and 2029
  • 7.4 Threat of new entrants
    • Threat of new entrants - Impact of key factors in 2024 and 2029
  • 7.5 Threat of substitutes
    • Threat of substitutes - Impact of key factors in 2024 and 2029
  • 7.6 Threat of rivalry
    • Threat of rivalry - Impact of key factors in 2024 and 2029
  • 7.7 Market condition
    • Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Product Type

  • 8.1 Market segments
    • Chart on Product Type - Market share 2024-2029 (%)
    • Data Table on Product Type - Market share 2024-2029 (%)
  • 8.2 Comparison by Product Type
    • Chart on Comparison by Product Type
    • Data Table on Comparison by Product Type
  • 8.3 GHMM - Market size and forecast 2024-2029
    • Chart on GHMM - Market size and forecast 2024-2029 ($ million)
    • Data Table on GHMM - Market size and forecast 2024-2029 ($ million)
    • Chart on GHMM - Year-over-year growth 2024-2029 (%)
    • Data Table on GHMM - Year-over-year growth 2024-2029 (%)
  • 8.4 Cell-based humanized mouse model - Market size and forecast 2024-2029
    • Chart on Cell-based humanized mouse model - Market size and forecast 2024-2029 ($ million)
    • Data Table on Cell-based humanized mouse model - Market size and forecast 2024-2029 ($ million)
    • Chart on Cell-based humanized mouse model - Year-over-year growth 2024-2029 (%)
    • Data Table on Cell-based humanized mouse model - Year-over-year growth 2024-2029 (%)
  • 8.5 Market opportunity by Product Type
    • Market opportunity by Product Type ($ million)
    • Data Table on Market opportunity by Product Type ($ million)

9 Market Segmentation by End-user

  • 9.1 Market segments
    • Chart on End-user - Market share 2024-2029 (%)
    • Data Table on End-user - Market share 2024-2029 (%)
  • 9.2 Comparison by End-user
    • Chart on Comparison by End-user
    • Data Table on Comparison by End-user
  • 9.3 Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029
    • Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029 ($ million)
    • Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2024-2029 ($ million)
    • Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2024-2029 (%)
    • Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2024-2029 (%)
  • 9.4 CROs - Market size and forecast 2024-2029
    • Chart on CROs - Market size and forecast 2024-2029 ($ million)
    • Data Table on CROs - Market size and forecast 2024-2029 ($ million)
    • Chart on CROs - Year-over-year growth 2024-2029 (%)
    • Data Table on CROs - Year-over-year growth 2024-2029 (%)
  • 9.5 Academic and research institutions - Market size and forecast 2024-2029
    • Chart on Academic and research institutions - Market size and forecast 2024-2029 ($ million)
    • Data Table on Academic and research institutions - Market size and forecast 2024-2029 ($ million)
    • Chart on Academic and research institutions - Year-over-year growth 2024-2029 (%)
    • Data Table on Academic and research institutions - Year-over-year growth 2024-2029 (%)
  • 9.6 Market opportunity by End-user
    • Market opportunity by End-user ($ million)
    • Data Table on Market opportunity by End-user ($ million)

10 Market Segmentation by Application

  • 10.1 Market segments
    • Chart on Application - Market share 2024-2029 (%)
    • Data Table on Application - Market share 2024-2029 (%)
  • 10.2 Comparison by Application
    • Chart on Comparison by Application
    • Data Table on Comparison by Application
  • 10.3 Oncology - Market size and forecast 2024-2029
    • Chart on Oncology - Market size and forecast 2024-2029 ($ million)
    • Data Table on Oncology - Market size and forecast 2024-2029 ($ million)
    • Chart on Oncology - Year-over-year growth 2024-2029 (%)
    • Data Table on Oncology - Year-over-year growth 2024-2029 (%)
  • 10.4 Immunology and infectious diseases - Market size and forecast 2024-2029
    • Chart on Immunology and infectious diseases - Market size and forecast 2024-2029 ($ million)
    • Data Table on Immunology and infectious diseases - Market size and forecast 2024-2029 ($ million)
    • Chart on Immunology and infectious diseases - Year-over-year growth 2024-2029 (%)
    • Data Table on Immunology and infectious diseases - Year-over-year growth 2024-2029 (%)
  • 10.5 Neuroscience - Market size and forecast 2024-2029
    • Chart on Neuroscience - Market size and forecast 2024-2029 ($ million)
    • Data Table on Neuroscience - Market size and forecast 2024-2029 ($ million)
    • Chart on Neuroscience - Year-over-year growth 2024-2029 (%)
    • Data Table on Neuroscience - Year-over-year growth 2024-2029 (%)
  • 10.6 Toxicology and hematopoiesis - Market size and forecast 2024-2029
    • Chart on Toxicology and hematopoiesis - Market size and forecast 2024-2029 ($ million)
    • Data Table on Toxicology and hematopoiesis - Market size and forecast 2024-2029 ($ million)
    • Chart on Toxicology and hematopoiesis - Year-over-year growth 2024-2029 (%)
    • Data Table on Toxicology and hematopoiesis - Year-over-year growth 2024-2029 (%)
  • 10.7 Market opportunity by Application
    • Market opportunity by Application ($ million)
    • Data Table on Market opportunity by Application ($ million)

11 Customer Landscape

  • 11.1 Customer landscape overview
    • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

  • 12.1 Geographic segmentation
    • Chart on Market share By Geographical Landscape 2024-2029 (%)
    • Data Table on Market share By Geographical Landscape 2024-2029 (%)
  • 12.2 Geographic comparison
    • Chart on Geographic comparison
    • Data Table on Geographic comparison
  • 12.3 North America - Market size and forecast 2024-2029
    • Chart on North America - Market size and forecast 2024-2029 ($ million)
    • Data Table on North America - Market size and forecast 2024-2029 ($ million)
    • Chart on North America - Year-over-year growth 2024-2029 (%)
    • Data Table on North America - Year-over-year growth 2024-2029 (%)
  • 12.4 Europe - Market size and forecast 2024-2029
    • Chart on Europe - Market size and forecast 2024-2029 ($ million)
    • Data Table on Europe - Market size and forecast 2024-2029 ($ million)
    • Chart on Europe - Year-over-year growth 2024-2029 (%)
    • Data Table on Europe - Year-over-year growth 2024-2029 (%)
  • 12.5 Asia - Market size and forecast 2024-2029
    • Chart on Asia - Market size and forecast 2024-2029 ($ million)
    • Data Table on Asia - Market size and forecast 2024-2029 ($ million)
    • Chart on Asia - Year-over-year growth 2024-2029 (%)
    • Data Table on Asia - Year-over-year growth 2024-2029 (%)
  • 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
    • Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
    • Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
    • Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
  • 12.7 US - Market size and forecast 2024-2029
    • Chart on US - Market size and forecast 2024-2029 ($ million)
    • Data Table on US - Market size and forecast 2024-2029 ($ million)
    • Chart on US - Year-over-year growth 2024-2029 (%)
    • Data Table on US - Year-over-year growth 2024-2029 (%)
  • 12.8 China - Market size and forecast 2024-2029
    • Chart on China - Market size and forecast 2024-2029 ($ million)
    • Data Table on China - Market size and forecast 2024-2029 ($ million)
    • Chart on China - Year-over-year growth 2024-2029 (%)
    • Data Table on China - Year-over-year growth 2024-2029 (%)
  • 12.9 Germany - Market size and forecast 2024-2029
    • Chart on Germany - Market size and forecast 2024-2029 ($ million)
    • Data Table on Germany - Market size and forecast 2024-2029 ($ million)
    • Chart on Germany - Year-over-year growth 2024-2029 (%)
    • Data Table on Germany - Year-over-year growth 2024-2029 (%)
  • 12.10 France - Market size and forecast 2024-2029
    • Chart on France - Market size and forecast 2024-2029 ($ million)
    • Data Table on France - Market size and forecast 2024-2029 ($ million)
    • Chart on France - Year-over-year growth 2024-2029 (%)
    • Data Table on France - Year-over-year growth 2024-2029 (%)
  • 12.11 Canada - Market size and forecast 2024-2029
    • Chart on Canada - Market size and forecast 2024-2029 ($ million)
    • Data Table on Canada - Market size and forecast 2024-2029 ($ million)
    • Chart on Canada - Year-over-year growth 2024-2029 (%)
    • Data Table on Canada - Year-over-year growth 2024-2029 (%)
  • 12.12 Japan - Market size and forecast 2024-2029
    • Chart on Japan - Market size and forecast 2024-2029 ($ million)
    • Data Table on Japan - Market size and forecast 2024-2029 ($ million)
    • Chart on Japan - Year-over-year growth 2024-2029 (%)
    • Data Table on Japan - Year-over-year growth 2024-2029 (%)
  • 12.13 Brazil - Market size and forecast 2024-2029
    • Chart on Brazil - Market size and forecast 2024-2029 ($ million)
    • Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
    • Chart on Brazil - Year-over-year growth 2024-2029 (%)
    • Data Table on Brazil - Year-over-year growth 2024-2029 (%)
  • 12.14 UK - Market size and forecast 2024-2029
    • Chart on UK - Market size and forecast 2024-2029 ($ million)
    • Data Table on UK - Market size and forecast 2024-2029 ($ million)
    • Chart on UK - Year-over-year growth 2024-2029 (%)
    • Data Table on UK - Year-over-year growth 2024-2029 (%)
  • 12.15 India - Market size and forecast 2024-2029
    • Chart on India - Market size and forecast 2024-2029 ($ million)
    • Data Table on India - Market size and forecast 2024-2029 ($ million)
    • Chart on India - Year-over-year growth 2024-2029 (%)
    • Data Table on India - Year-over-year growth 2024-2029 (%)
  • 12.16 South Korea - Market size and forecast 2024-2029
    • Chart on South Korea - Market size and forecast 2024-2029 ($ million)
    • Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
    • Chart on South Korea - Year-over-year growth 2024-2029 (%)
    • Data Table on South Korea - Year-over-year growth 2024-2029 (%)
  • 12.17 Market opportunity By Geographical Landscape
    • Market opportunity By Geographical Landscape ($ million)
    • Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

  • 13.1 Market drivers
  • 13.2 Market challenges
  • 13.3 Impact of drivers and challenges
    • Impact of drivers and challenges in 2024 and 2029
  • 13.4 Market opportunities/restraints

14 Competitive Landscape

  • 14.1 Overview
  • 14.2 Competitive Landscape
    • Overview on criticality of inputs and factors of differentiation
  • 14.3 Landscape disruption
    • Overview on factors of disruption
  • 14.4 Industry risks
    • Impact of key risks on business

15 Competitive Analysis

  • 15.1 Companies profiled
    • Companies covered
  • 15.2 Company ranking index
    • Company ranking index
  • 15.3 Market positioning of companies
    • Matrix on companies position and classification
  • 15.4 Altogen labs
    • Altogen labs - Overview
    • Altogen labs - Product / Service
    • Altogen labs - Key offerings
    • SWOT
  • 15.5 Aragen Life Sciences Pvt. Ltd.
    • Aragen Life Sciences Pvt. Ltd. - Overview
    • Aragen Life Sciences Pvt. Ltd. - Product / Service
    • Aragen Life Sciences Pvt. Ltd. - Key offerings
    • SWOT
  • 15.6 Biocytogen Pharmaceuticals Co. Ltd.
    • Biocytogen Pharmaceuticals Co. Ltd. - Overview
    • Biocytogen Pharmaceuticals Co. Ltd. - Product / Service
    • Biocytogen Pharmaceuticals Co. Ltd. - Key offerings
    • SWOT
  • 15.7 BioSafety Research Center Inc.
    • BioSafety Research Center Inc. - Overview
    • BioSafety Research Center Inc. - Product / Service
    • BioSafety Research Center Inc. - Key offerings
    • SWOT
  • 15.8 Champions Oncology Inc.
    • Champions Oncology Inc. - Overview
    • Champions Oncology Inc. - Product / Service
    • Champions Oncology Inc. - Key offerings
    • SWOT
  • 15.9 Charles River Laboratories International Inc.
    • Charles River Laboratories International Inc. - Overview
    • Charles River Laboratories International Inc. - Business segments
    • Charles River Laboratories International Inc. - Key offerings
    • Charles River Laboratories International Inc. - Segment focus
    • SWOT
  • 15.10 Creative Biolabs
    • Creative Biolabs - Overview
    • Creative Biolabs - Product / Service
    • Creative Biolabs - Key offerings
    • SWOT
  • 15.11 Cyagen Biosciences
    • Cyagen Biosciences - Overview
    • Cyagen Biosciences - Product / Service
    • Cyagen Biosciences - Key offerings
    • SWOT
  • 15.12 Gempharmatech Co. Ltd.
    • Gempharmatech Co. Ltd. - Overview
    • Gempharmatech Co. Ltd. - Product / Service
    • Gempharmatech Co. Ltd. - Key offerings
    • SWOT
  • 15.13 GenOway
    • GenOway - Overview
    • GenOway - Product / Service
    • GenOway - Key offerings
    • SWOT
  • 15.14 HBM Holdings Ltd.
    • HBM Holdings Ltd. - Overview
    • HBM Holdings Ltd. - Product / Service
    • HBM Holdings Ltd. - Key offerings
    • SWOT
  • 15.15 Hera Biolabs Inc.
    • Hera Biolabs Inc. - Overview
    • Hera Biolabs Inc. - Product / Service
    • Hera Biolabs Inc. - Key offerings
    • SWOT
  • 15.16 ingenious targeting laboratory
    • ingenious targeting laboratory - Overview
    • ingenious targeting laboratory - Product / Service
    • ingenious targeting laboratory - Key offerings
    • SWOT
  • 15.17 JSR Corp.
    • JSR Corp. - Overview
    • JSR Corp. - Business segments
    • JSR Corp. - Key offerings
    • JSR Corp. - Segment focus
    • SWOT
  • 15.18 Perkin Elmer Inc.
    • Perkin Elmer Inc. - Overview
    • Perkin Elmer Inc. - Business segments
    • Perkin Elmer Inc. - Key offerings
    • Perkin Elmer Inc. - Segment focus
    • SWOT

16 Appendix

  • 16.1 Scope of the report
  • 16.2 Inclusions and exclusions checklist
    • Inclusions checklist
    • Exclusions checklist
  • 16.3 Currency conversion rates for US$
    • Currency conversion rates for US$
  • 16.4 Research methodology
    • Research methodology
  • 16.5 Data procurement
    • Information sources
  • 16.6 Data validation
    • Data validation
  • 16.7 Validation techniques employed for market sizing
    • Validation techniques employed for market sizing
  • 16.8 Data synthesis
    • Data synthesis
  • 16.9 360 degree market analysis
    • 360 degree market analysis
  • 16.10 List of abbreviations
    • List of abbreviations
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦